drugset / Trial / NCT04344379
Prevention of SARS-CoV-2 in Hospital Workers s Exposed to the Virus
Phase 3
Completed
122 enrolled
Assistance Publique - Hôpitaux de Paris
URC-CIC Paris Descartes Necker Cochin · collab
RandomizedParallel-groupDouble-blindPrevention
Summary
The Investigators propose to set up a preventive trial of infection in hospital workers at risk of coronavirus infection by comparing the rate of SARS-Cov-2 infection in a population of negative SARS-Cov-2 hospital workers receiving preventively azithromycin, hydroxychloroquine or a Placebo
Timeline
- Start
- 2020-04-17
- Primary completion
- 2020-06-18
- Completion
- 2020-06-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Azithromycin | Small molecule | 250 mg | — |
| Comparator | Hydroxychloroquine | Small molecule | 200 mg | — |